Related Experiment Video
Updated: Feb 19, 2026
03:45
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
4.3K
A SCN4A mutation causing paramyotonia congenita.
Carmen Palma1, Carmen Prior1, Clara Gómez-González1
1Instituto de Genética Médica y Molecular, CIBERER, IdiPAZ, Hospital Universitario La Paz, Madrid, Spain.
Neuromuscular Disorders : NMD
|November 8, 2017
Summary
Paramyotonia congenita, a genetic muscle disorder, is caused by SCN4A gene mutations. This study identifies a specific SCN4A mutation responsible for paramyotonia congenita in an affected family.
Area of Science:
- Genetics
- Neurology
- Molecular Biology
Background:
- Paramyotonia congenita is a non-dystrophic myopathy linked to SCN4A gene mutations.
- It shares symptoms with myotonia congenita, leading to diagnostic challenges.
- SCN4A gene mutations can also cause potassium-aggravated myotonia.
Observation:
- A family presented with multiple members affected by paramyotonia congenita.
- Genetic analysis revealed a novel mutation in the SCN4A gene within the affected family members.
Findings:
- The identified SCN4A gene mutation segregated with the disease in the family.
- Computational analyses, including evolutionary conservation and pathogenicity prediction, supported the variant's causative role.
Implications:
- This finding clarifies the genetic basis of paramyotonia congenita in this family.
- It aids in differential diagnosis, distinguishing it from other myotonias.
- Understanding SCN4A mutations advances research into ion channelopathies and muscle disorders.
Related Concept Videos
01:21Satellite Stem Cells and Muscular Dystrophy
2.4K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.4K
01:26Chemical Synapses
12.0K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
12.0K
01:26Chemical Synapses
4.7K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
4.7K
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
540
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
540
01:48ATP Synthase: Mechanism
17.4K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
17.4K
01:39Mutations
94.7K
Overview
94.7K